Union Korea Pharm Co., Ltd. (KOSDAQ: A080720)
Health Care · Pharmaceuticals · KR
₩—
— today · — 1Y
Union Korea Pharm Co., Ltd. (KOSDAQ: A080720) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.59M.
trading between 7.35K and 19.38K.
Tweenvest scores Union Korea Pharm Co., Ltd. across four factors: quality 54/100, value 67/100. Its strongest factor is value.
A080720 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.59M
- Revenue (TTM)
- $16.44M
- P/E
- —
- EPS
- -4,721.34
- Dividend yield
- —
- Beta (5Y)
- 0.07
- 52-week high
- ₩19,380.00
- 52-week low
- ₩7,350.00
- Avg volume (3M)
- —
- Shares outstanding
- 2.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thalia Therapeutics PlcAIM: THAT | $14.69M | £0.01 | -0.80% |
| Vyome Holdings, Inc.NasdaqCM: HIND | $14.67M | $2.09 | +9.42% |
| Ambee Pharmaceuticals PLCDSE: AMBEEPHA | $14.65M | Tk752.00 | +1.43% |
| Godavari Drugs LimitedBSE: 530317 | $14.65M | Rs140.00 | +18.59% |
| Biofrontera Inc.NasdaqCM: BFRI | $14.41M | $0.97 | -4.43% |
| Bio Essence CorporationOTCPK: BIOE | $14.37M | $0.27 | — |
| Lobe Sciences Ltd.CNSX: LOBE | $14.28M | CA$0.06 | +9.09% |
| Lipocine Inc.NasdaqCM: LPCN | $14.18M | $1.72 | -16.10% |
Figures last refreshed Oct 11, 2026.